132 research outputs found
Palm Oil and Beta-palmitate in Infant Formula: A Position Paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition
Background:
Palm oil (PO) is used in infant formulas in order to achieve palmitic acid (PA) levels similar to those in human milk. PA in PO is esterified predominantly at the SN-1,3 position of triacylglycerol (TAG), and infant formulas are now available in which a greater proportion of PA is in the SN-2 position (typical configuration in human milk). As there are some concerns about the use of PO, we aimed to review literature on health effects of PO and SN-2-palmitate in infant formulas. /
Methods:
PubMed and Cochrane Database of Systematic Reviews were systematically searched for relevant studies on possible beneficial effects or harms of either PO or SN-2-palmitate in infant formula on various health outcomes. /
Results:
We identified 12 relevant studies using PO and 21 studies using SN-2-palmitate. Published studies have variable methodology, subject characteristics, and some are underpowered for the key outcomes. PO is associated with harder stools and SN-2-palmitate use may lead to softer stool consistency. Bone effects seem to be short-lasting. For some outcomes (infant colic, faecal microbiota, lipid metabolism), the number of studies is very limited and summary evidence inconclusive. Growth of infants is not influenced. There are no studies published on the effect on markers of later diseases. /
Conclusions:
There is insufficient evidence to suggest that PO should be avoided as a source of fat in infant formulas for health reasons. Inclusion of high SN-2-palmitate fat blend in infant formulas may have short-term effects on stool consistency but cannot be considered essential
Developing cardiac and skeletal muscle share fast-skeletal myosin heavy chain and cardiac troponin-I expression
Skeletal muscle derived stem cells (MDSCs) transplanted into injured myocardium can differentiate into fast skeletal muscle specific myosin heavy chain (sk-fMHC) and cardiac specific troponin-I (cTn-I) positive cells sustaining recipient myocardial function. We have recently found that MDSCs differentiate into a cardiomyocyte phenotype within a three-dimensional gel bioreactor. It is generally accepted that terminally differentiated myocardium or skeletal muscle only express cTn-I or sk-fMHC, respectively. Studies have shown the presence of non-cardiac muscle proteins in the developing myocardium or cardiac proteins in pathological skeletal muscle. In the current study, we tested the hypothesis that normal developing myocardium and skeletal muscle transiently share both sk-fMHC and cTn-I proteins. Immunohistochemistry, western blot, and RT-PCR analyses were carried out in embryonic day 13 (ED13) and 20 (ED20), neonatal day 0 (ND0) and 4 (ND4), postnatal day 10 (PND10), and 8 week-old adult female Lewis rat ventricular myocardium and gastrocnemius muscle. Confocal laser microscopy revealed that sk-fMHC was expressed as a typical striated muscle pattern within ED13 ventricular myocardium, and the striated sk-fMHC expression was lost by ND4 and became negative in adult myocardium. cTn-I was not expressed as a typical striated muscle pattern throughout the myocardium until PND10. Western blot and RT-PCR analyses revealed that gene and protein expression patterns of cardiac and skeletal muscle transcription factors and sk-fMHC within ventricular myocardium and skeletal muscle were similar at ED20, and the expression patterns became cardiac or skeletal muscle specific during postnatal development. These findings provide new insight into cardiac muscle development and highlight previously unknown common developmental features of cardiac and skeletal muscle. © 2012 Clause et al
Care during the third stage of labour: obstetricians views and practice in an Albanian maternity hospital
<p>Abstract</p> <p>Background</p> <p>Relatively little is known about current practice during the third stage of labour in low and middle income countries. We conducted a survey of attitudes and an audit of practice in a large maternity hospital in Albania.</p> <p>Methods</p> <p>Survey of 35 obstetricians and audit of practice during the third stage was conducted in July 2008 at a tertiary referral hospital in Tirana. The survey questionnaire was self completed. Responses were anonymous. For the audit, information collected included time of administration of the uterotonic drug, gestation at birth, position of the baby before cord clamping, cord traction, and need for resuscitation.</p> <p>Results</p> <p>77% (27/35) of obstetricians completed the questionnaire, of whom 78% (21/27) reported always or usually using active management, and 22% (6/27) always or usually using physiological care. When using active management: 56% (15/27) gave the uterotonic after cord clamping; intravenous oxytocin was almost always the drug used; and 71% (19/27) clamped the cord within one minute. For physiological care: 42% (8/19) clamped the cord within 20 seconds, and 96% (18/19) within one minute. 93% would randomise women to a trial of early versus late cord clamping.</p> <p>Practice was observed for 156 consecutive births, of which 26% (42/156) were by caesarean section. A prophylactic uterotonic was used for 87% (137/156): this was given after cord clamping for 55% (75/137), although timing of administration was not recorded for 21% (29/137). For 85% of births (132/156) cord clamping was within 20 seconds, and for all babies it was within 50 seconds. Controlled cord traction was used for 49% (76/156) of births.</p> <p>Conclusions</p> <p>Most obstetricians reported always or usually using active management for the third stage of labour. For timing and choice of the uterotonic drug, reported practice was similar to actual practice. Although some obstetricians reported they waited longer than one minute before clamping the cord, this was not observed in practice. Controlled cord traction was used for half the births.</p
Quality and Safety Aspects of Infant Nutrition
Quality and safety aspects of infant nutrition are of key importance for child health, but oftentimes they do not get much attention by health care professionals whose interest tends to focus on functional benefits of early nutrition. Unbalanced diets and harmful food components induce particularly high risks for untoward effects in infants because of their rapid growth, high nutrient needs, and their typical dependence on only one or few foods during the first months of life. The concepts, standards and practices that relate to infant food quality and safety were discussed at a scientific workshop organized by the Child Health Foundation and the Early Nutrition Academy jointly with the European Society for Paediatric Gastroenterology, Hepatology and Nutrition, and a summary is provided here. The participants reviewed past and current issues on quality and safety, the role of different stakeholders, and recommendations to avert future issues. It was concluded that a high level of quality and safety is currently achieved, but this is no reason for complacency. The food industry carries the primary responsibility for the safety and suitability of their products, including the quality of composition, raw materials and production processes. Introduction of new or modified products should be preceded by a thorough science based review of suitability and safety by an independent authority. Food safety events should be managed on an international basis. Global collaboration of food producers, food-safety authorities, paediatricians and scientists is needed to efficiently exchange information and to best protect public health. Copyright (C) 2012 S. Karger AG, Base
Research priorities in pediatric parenteral nutrition: a consensus and perspective from ESPGHAN/ESPEN/ESPR/CSPEN
We acknowledge all the authors of the ESPGHAN/ESPR/ESPEN/CSPEN pediatric
parenteral nutrition guidelines for their contributions and vote (Christian Braegger,
University Children’s Hospital, Zurich, Switzerland; Jiri Bronsky, University Hospital
Motol, Prague, Czech Republic; Cristina Campoy, Department of Paediatrics, School of
Medicine, University of Granada, Granada, Spain; Magnus Domellof, Department of
Clinical Sciences, Pediatrics, Umeå University, Sweden; Nicholas Embleton, Newcastle
University, Newcastle upon Tyne, UK; Mary Fewtrell, UCL Great Ormond Street
Institute of Child Health, London, UK; Natasa Fidler, University Medical Centre
Ljubljana, Ljubljana, Slovenia; Axel Franz, University Children’s Hospital, Tuebingen,
Germany; Oliver Goulet, University Sordonne-Paris-Cite; Paris-Descartes Medical
School, Paris, France; Corina Hartmann, Schneider Children’s Medical Center of Israel,
Petach Tikva, Israel and Carmel Medical Center, Israel; Susan Hill, Great Ormond Street
Hospital for Children, NHS Foundation Trust and UCL Institute of Child Health,
London, UK; Iva Hojsak, Children’s Hospital Zagreb, University of Zagreb School of
Medicine, University of J. J. Strossmayer School of Medicine Osijek, Croatia; Sylvia
Iacobelli, CHU La Reunion, Saint Pierre, France; Frank Jochum, Ev. Waldkrankenhaus
Spandau, Berlin, Germany; Koen Joosten, Department of Pediatrics and Pediatric
Surgery, Intensive Care, Erasmus MC Sophia Children’s Hospital, Rotterdam, The
Netherlands; Sanja Kolacek, Children’s Hospital, University of Zagreb School of
Medicine, Zagreb, Croatia; Alexandre Lapillone, Paris-Descartes University, Paris,
France; Szimonetta Lohner, Department of Pediatrics, University of Pecs, Pecs,
Hungary; Dieter Mesotten, KU Leuven, Leuven, Belgium; Walter Mihatsch, Ulm
University, Ulm, and Helios Hospital, Pforzheim, Germany; Francis Mimouni,
Department of Pediatrics, Division of Neonatology, The Wilf Children’s Hospital, the
Shaare Zedek Medical Center, Jerusalem, and the Tel Aviv University, Tel Aviv, Israel;
Christian Molgaard, Department of Nutrition, Exercise and Sports, University of
Copenhagen, and Paediatric Nutrition Unit, Rigshospitalet, Copenhagen, Denmark;
Sissel Moltu, Oslo University Hospital, Oslo, Norway; Antonia Nomayo, Ev.
Waldkrankenhaus Spandau, Berlin, Germany; John Puntis, The General Infirmary at
Leeds, Leeds, UK; Arieh Riskin, Bnai Zion Medical Center, Rappaport Faculty of
Medicine, Technion, Haifa, Israel; Miguel Saenz de Pipaon, Department of
Neonatology, La Paz University Hospital, Red de Salud Materno Infantil y Desarrollo
e SAMID, Universidad Autonoma de Madrid, Madrid, Spain; Raanan Shamir, Schneider
Children’s Medical Center of Israel, Petach Tikva, Israel; Tel Aviv University, Tel Aviv,
Israel; Peter Szitanyi, General University Hospital, First Faculty of Medicine, Charles
University in Prague, Czech Republic; Merit Tabbers, Emma Children’s Hospital,
Amsterdam UMC, Amsterdam, The Netherlands; Chris van den Akker, Emma
Children’s Hospital, Amsterdam UMC, Amsterdam, The Netherlands; Hans van
Goudoever, Emma Children’s Hospital, Amsterdam UMC, Amsterdam, The Netherlands;
Sacha Verbruggen, Department of Pediatrics and Pediatric Surgery, Intensive
Care, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands; Cai Wei,
Shanghai Jiao Tong University, Shanghai, China; Weihui Yan, Department of
Gastroenterology and Nutrition, Xinhua Hospital, School of Medicine, Shanghai Jiao
Tong University, Shanghai, China) and the members of the ESPR Section on Nutrition,
Gastroenterology and Metabolism (Fredrik Ahlsson, Uppsala University Children’s
Hospital and Department of Women’s and Children’s Health, Uppsala University,
Uppsala, Sweden; Sertac Arslanoglu, Division of Neonatology, Department of
Pediatrics, Istanbul Medeniyet University, Istanbul, Turkey; Wolfgang Bernhard,
Department of Neonatology, Children’s Hospital, Faculty of Medicine, Eberhard-Karls-
University, Tübingen, Germany; Janet Berrington, Newcastle Neonatal Service,
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;
Signe Bruun, Hans Christian Andersen Hospital for Children and Adolescents, Odense
University Hospital, Odense, Denmark; Christoph Fusch, Department of Pediatrics, Paracelsus Medical School, General Hospital of Nuremberg, Nuremberg, Germany;
Shalabh Garg, South Tees Hospitals, Middlesborough, UK; Maria Gianni, Department
of Clinical Sciences and Community Health, University of Milan, Milan, Italy; Ann
Hellstrom, Institute of Neuroscience and Physiology, Sahlgrenska Academy at
University of Gothenburg, Gothenburg, Sweden; Claus Klingenberg, Department of
Pediatrics and Adolescence Medicine, University Hospital of North Norway, Tromsø,
Norway; Helen Mactier, Neonatal Unit, Princess Royal Maternity Hospital, Glasgow,
UK; Neena Modi, Section of Neonatal Medicine, Department of Medicine, Chelsea and
Westminster Campus, Imperial College London, London, UK; Niels Rochow, Division
of Neonatology, Department of Pediatrics, McMaster University, Hamilton, Ontario,
Canada; Paola Rogerro, Department of Clinical Sciences and Community Health,
University of Milan, Milan, Italy; Umberto Simeoni, Division of Pediatrics, CHUV &
University of Lausanne, Lausanne, Switzerland; Atul Singhal, Paediatric Nutrition, UCL
Great Ormond Street Institute of Child Health, London, UK.; Ulrich Thome,
Department of Neonatology, Universitatsklinikum Leipzig, Leipzig, Germany; Anne
Twomey, Department of Neonatology, The National Maternity Hospital, Dublin,
Ireland; Mireille Vanpee, Karolinska University Hospital, Stockholm, Sweden; Gitte
Zachariassen, Hans Christian Andersen Hospital for Children and Adolescents,
Odense University Hospital, Odense, Denmark) for their vote.Parenteral nutrition is used to treat children that cannot be fully fed by the enteral route. While the revised ESPGHAN/
ESPEN/ESPR/CSPEN pediatric parenteral nutrition guidelines provide clear guidance on the use of parenteral nutrition in neonates,
infants, and children based on current available evidence, they have helped to crystallize areas where research is lacking or more
studies are needed in order to refine recommendations. This paper collates and discusses the research gaps identified by the
authors of each section of the guidelines and considers each nutrient or group of nutrients in turn, together with aspects around
delivery and organization. The 99 research priorities identified were then ranked in order of importance by clinicians and
researchers working in the field using a survey methodology. The highest ranked priority was the need to understand the
relationship between total energy intake, rapid catch-up growth, later metabolic function, and neurocognitive outcomes. Research
into the optimal intakes of macronutrients needed in order to achieve optimal outcomes also featured prominently. Identifying
research priorities in PN should enable research to be focussed on addressing key issues. Multicentre trials, better definition of
exposure and outcome variables, and long-term metabolic and developmental follow-up will be key to achieving this
Research priorities in pediatric parenteral nutrition: a consensus and perspective from ESPGHAN/ESPEN/ESPR/CSPEN
Parenteral nutrition is used to treat children that cannot be fully fed by the enteral route. While the revised ESPGHAN/ESPEN/ESPR/CSPEN pediatric parenteral nutrition guidelines provide clear guidance on the use of parenteral nutrition in neonates, infants, and children based on current available evidence, they have helped to crystallize areas where research is lacking or more studies are needed in order to refine recommendations. This paper collates and discusses the research gaps identified by the authors of each section of the guidelines and considers each nutrient or group of nutrients in turn, together with aspects around delivery and organization. The 99 research priorities identified were then ranked in order of importance by clinicians and researchers working in the field using a survey methodology. The highest ranked priority was the need to understand the relationship between total energy intake, rapid catch-up growth, later metabolic function, and neurocognitive outcomes. Research into the optimal intakes of macronutrients needed in order to achieve optimal outcomes also featured prominently. Identifying research priorities in PN should enable research to be focussed on addressing key issues. Multicentre trials, better definition of exposure and outcome variables, and long-term metabolic and developmental follow-up will be key to achieving this. Impact: The recent ESPGHAN/ESPEN/ESPR/CSPEN guidelines for pediatric parenteral nutrition provided updated guidance for providing parenteral nutrition to infants and children, including recommendations for practice.However, in several areas there was a lack of evidence to guide practice, or research questions that remained unanswered. This paper summarizes the key priorities for research in pediatric parenteral nutrition, and ranks them in order of importance according to expert opinion
Micronutrient status in lactating mothers before and after introduction of fortified flour: cross-sectional surveys in Maela refugee camp
Background Deficiency of micronutrients is common in refugee populations. Objectives Identify deficiencies and whether provided supplements and wheat flour fortified with 10 micronutrients impacts upon status among breast-feeding women from Maela refugee camp. Methods Two sequential cross-sectional studies were conducted in different groups of lactating mothers at 12 weeks postpartum. The first survey was before and the second 4-5 months after micronutrient fortified flour (MFF) had been provided to the camp (in addition to the regular food basket). Iron status and micronutrients were measured in serum, whole blood, and in breast milk samples. Results Iron and zinc deficiency and anemia were highly prevalent while low serum retinol and thiamine deficiency were rarely detected. Iron and zinc deficiency were associated with anemia, and their proportions were significantly lower after the introduction of MFF (21 vs. 35% with soluble transferrin receptor (sTfR)>8.5 mg/L, P = 0.042, and 50 vs. 73% with serum zinc<0.66 mg/L, P = 0.001). Serum sTfR, whole-blood thiamine diphosphate (TDP) and serum β-carotene were significant predictors (P<0.001) of milk iron, thiamine and β-carotene, respectively. Lower prevalence of iron deficiency in the MFF group was associated with significantly higher iron and thiamine in breast milk. Conclusions High whole-blood TDP and breast milk thiamine reflected good compliance to provided thiamine; high prevalence of iron deficiency suggested insufficient dietary iron and low acceptance to ferrous sulfate supplements. MFF as an additional food ration in Maela refugee camp seemed to have an effect in reducing both iron and zinc deficiency postpartum. © Springer-Verlag 2012
Current State of Gastric Stump Carcinoma in Japan: Based on the Results of a Nationwide Survey
Neonatal erythropoiesis and subsequent anemia in HIV-positive and HIV-negative Zimbabwean babies during the first year of life: a longitudinal study
BACKGROUND: Anemia is common in HIV infection and independently associated with disease progression and mortality. The pathophysiology of HIV-related anemia is not well understood especially in infancy. METHODS: We conducted a longitudinal cohort study nested within the Zimbabwe Vitamin A for Mothers and Babies Project. We measured hemoglobin, erythropoietin (EPO), serum transferrin receptor (TfR) and serum ferritin at 6 weeks, 3 and 6 months of age and hemoglobin at 9 and 12 months in 3 groups of randomly selected infants: 136 born to HIV-negative mothers, and 99 born to HIV-positive mothers and who were infected themselves by 6 weeks of age, and 324 born to HIV-positive mothers but who did not become infected in the 6 months following birth. RESULTS: At one year of age, HIV-positive infants were 5.26 (adjusted odds ratio, P < 0.001) times more likely to be anemic compared to HIV-negative infants. Among, HIV-negative infants, EPO was or tended to be inversely associated with hemoglobin and was significantly positively associated with TfR throughout the first 6 months of life; TfR was significantly inversely associated with ferritin at 6 months; and EPO explained more of the variability in TfR than did ferritin. Among infected infants, the inverse association of EPO to hemoglobin was attenuated during early infancy, but significant at 6 months. Similar to HIV-negative infants, EPO was significantly positively associated with TfR throughout the first 6 months of life. However, the inverse association between TfR and ferritin observed among HIV-negative infants at 6 months was not observed among infected infants. Between birth and 6 months, mean serum ferritin concentration declined sharply (by ~90%) in all three groups of babies, but was significantly higher among HIV-positive compared to HIV-negative babies at all time points. CONCLUSION: HIV strongly increases anemia risk and confounds interpretation of hematologic indicators in infants. Among HIV-infected infants, the EPO response to anemia is attenuated near the time of infection in the first weeks of life, but normalizes by 6 months
- …